\
&
Contact us
\
&
Contact us
This was 4 years ago
Locationvirtual
ProgrammesThe Falling Walls Lab Marie Skłodowska-Curie Actions (MSCA) is a pitch competition organised by the European Commission in cooperation with the Falling Walls Lab. 15 selected MSCA fellows will present – in 3 minutes each – their research topic, innovative project, social initiative, business model, or idea through a video pitch to peers, a jury made up of experts from academia and business, and the general public.
The Falling Walls Lab MSCA competition will take place online-only on 30 September 2021. Before the competition, participants will take part in coaching sessions to practise their communication and storytelling skills, get tips for video presentations and speeches and receive personalised advice from a professional coach. Competitors will be assisted to record a professional video pitch.
The Falling Walls Lab MSCA will nominate three finalists plus there is an audience prize. All finalists will get a prize.
The call for applications is currently open for ongoing MSCA fellows at the application deadline 4 July 2021. All information on the application and eligibility criteria can be found in the online announcement.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
